Increased expression of miR-374b-5p in KCs after E. multilocularis infection
Protoscolices were collected from the E. multilocularis-infected Mongolian gerbil (Fig. 1A). Previous research has shown that miR-374b-5p was involved in pathogen-mediated inflammation [18, 19]. To examine the expression of miR-374b-5p in mouse KCs during E. multilocularis infection, the primary KCs were obtained from the liver of E. multilocularis-infected mice (Fig. 1B, C). The qRT-PCR result showed that the level of miR-374b-5p was significantly increased at 2 months post-infection (Fig. 1D).
miR-374b-5p was directly bound to the 3'-UTR of C/EBP β and suppressed its expression
To determine the potential role of miR-374b-5p in KCs during E. multilocularis infection, its potential targets were predicted by TargetScan and miRDB databases. A total of 8 potential targets, mainly associated with immune response, were screened out and visualized by qRT-PCR. Amongst only C/EBP β gene was significantly down-regulated in miR-374b-5p-overexpressed KCs (Fig. S1). Further analysis showed that there is a single binding site of miR-374b-5p in 3′-UTR of C/EBP β (Fig. 2A). Luciferase reporter assay revealed that the miR-374b-5p significantly decreased the luciferase activity in the HEK293T cells transfected with pmirGLO-C/EBP β-WT compared with that in the NC control (Fig. 2B). However, the decrease was not observed in the HEK293T cells transfected with pmirGLO-C/EBP β-Mut (Fig. 2B), suggesting that miR-374b-5p is able to bind to the 3′-UTR of C/EBP β. Furthermore, the expressions of C/EBP β were significantly inhibited at mRNA and protein levels in the miR-374b-5p-overexpressed KCs. Consistently, C/EBP β was significantly elevated at both mRNA and protein levels after downregulation of miR-374b-5p in the KCs by transfecting with miR-374b-5p inhibitor (Fig. 2C, D, E). Moreover, the expression of C/EBP β was negatively correlated with the miR-374b-5p expression in the KCs from E. multilocularis-infected mice (Fig. 2F). Above results suggest that miR-374b-5p was able to directly target to the 3′-UTR of C/EBP β and thereby suppressed C/EBP β expression.
Overexpression of miR-374b-5p inhibited the expression of NF-κBp65
In order to study the effect of miR-374b-5p-mediated C/EBP β on the NF-κB signaling pathway, the primary mice KCs were isolated. We found the protein levels of NF-κBp65 and p-NF-κBp65 were significantly down-regulated in the KCs transfected with miR-374b-5p mimics, while their protein levels were significantly up-regulated after transfection with miR-374b-5p inhibitor (Fig. 3A, B). Consistently, the protein levels of NF-κBp65 and p-NF-κBp65 were significantly up-regulated in the KCs overexpressed C/EBP β (Fig. 3C). This indicated that miR-374b-5p-mediated C/EBP β may be involved in the regulation of NF-κB signaling pathways.
Overexpression of miR-374b-5p changed the level of inflammatory factors
In order to determine whether the miR-374b-5p influence on the expression of inflammatory factors, the expression levels of M1-type pro-inflammatory (iNOS, TNFα, and IL6) and M2-type anti-inflammatory factors (Arg1) were detect by qRT-PCR and western blot. The expression of iNOS, TNFα, and IL6 at both mRNA and protein levels were statistically down-regulated in the KCs transfected with miR-374b-5p mimics compared with miR-NC, while Arg1 expression was statistically up-regulated (Fig. 4A,C). After transfection with miR-374b-5p inhibitor, the expressions of those inflammatory factors were opposite to those in the miR-374b-5p-overexpressed KCs (Fig. 4B, D). Above all, miR-374b-5p probably induced M2-type anti-inflammatory factors while suppressed M1-type pro-inflammatory factors via C/EBP β/NF-κB signaling pathway.
The production of proinflammatory factors was inhibited in KCs from E. multilocularis-infected mice and treated with ESPs
The results showed that the expression of iNOS and TNFα were decreased in KCs at 2 months post-infection, while Arg1 was obviously increased (Fig. 5A). Interestingly, the expression of miR-374b-5p was up-regulated in KCs treated with 25µg ESPs (Fig. 5B), and its target gene C/EBP β were down-regulated (Fig. 5C). Furthermore, the protein expression of NF-κBp65 and p-NF-κBp65 were down-regulated in ESPs-treated KCs (Fig. 5D). The expression of iNOS, TNFα, and IL6 at mRNA and protein levels were statistically down-regulated in KCs treated with ESPs. The mRNA level of Arg1 had no changed after treatment with ESPs, but Arg1 protein was statistically up-regulated (Fig. 5E, F). All these findings demonstrated that the NF-κB signaling was inhibited after treating KCs with ESPs in vitro.